Venous Thromboembolism in COVID-19

被引:62
作者
Schulman, Sam [1 ,2 ]
Hu, Yu [3 ]
Konstantinides, Stavros [4 ,5 ]
机构
[1] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Dept Med, Hamilton, ON, Canada
[2] IM Sechenov First Moscow State Med Univ, Dept Obstet & Gynecol, Moscow, Russia
[3] Huazhong Univ Sci & Technol, Inst Hematol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China
[4] Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany
[5] Democritus Univ Thrace, Dept Cardiol, Thrace, Greece
关键词
COVID-19; D-dimer; risk assessment models; venous thromboembolism; prophylaxis; treatment; ACUTE PULMONARY-EMBOLISM; DEEP-VEIN THROMBOSIS; CLINICAL CHARACTERISTICS; MEDICAL PATIENTS; RISK; PNEUMONIA; INFECTION; THERAPY; IMPACT;
D O I
10.1055/s-0040-1718532
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The coronavirus disease 2019 (COVID-19) is our latest pandemic, preceded by the H1N1 swine flu in 2009, which lasted approximately 19 months. One of the special characteristics of COVID-19 is the propensity to cause venous thromboembolism (VTE). Thromboinflammation seems to play a prominent role in the pathogenesis. We will here review some mechanisms in the pathogenesis and discuss some hematological biomarkers, and also whether they serve as useful risk factors for VTE. The role of general risk assessment models for medically ill patients specifically in COVID-19 is appraised. The type of prophylaxis and particularly whether standard or augmented doses of chemoprophylaxis should be used is reviewed based on available evidence. We are also comparing recommendations from 10 different guidance or position/consensus statements. Treatment recommendations for patients with COVID-19 and pulmonary embolism are discussed with current general treatment guidelines as reference. Specifics for patients with COVID-19 are pointed out and the potential role of thrombolytic treatment is explored.
引用
收藏
页码:1642 / 1653
页数:12
相关论文
共 90 条
[1]   Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis [J].
Abdel-Wahab, N. ;
Talathi, S. ;
Lopez-Olivo, M. A. ;
Suarez-Almazor, M. E. .
LUPUS, 2018, 27 (04) :572-583
[2]   The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management [J].
Abou-Ismail, Mouhamed Yazan ;
Diamond, Akiva ;
Kapoor, Sargam ;
Arafah, Yasmin ;
Nayak, Lalitha .
THROMBOSIS RESEARCH, 2020, 194 :101-115
[3]   Thrombosis risk associated with COVID-19 infection. A scoping review [J].
Al-Ani, Fatimah ;
Chehade, Samer ;
Lazo-Langner, Alejro .
THROMBOSIS RESEARCH, 2020, 192 :152-160
[4]  
Al-Samkari H, 2020, RES PRACT THROMB S1, V4
[5]  
American Society of Hematology, 2020, COVID 19 VTE ANT FRE
[6]   A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score [J].
Barbar, S. ;
Noventa, F. ;
Rossetto, V. ;
Ferrari, A. ;
Brandolin, B. ;
Perlati, M. ;
De Bon, E. ;
Tormene, D. ;
Pagnan, A. ;
Prandoni, P. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (11) :2450-2457
[7]   Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum [J].
Barnes, Geoffrey D. ;
Burnett, Allison ;
Allen, Arthur ;
Blumenstein, Marilyn ;
Clark, Nathan P. ;
Cuker, Adam ;
Dager, William E. ;
Deitelzweig, Steven B. ;
Ellsworth, Stacy ;
Garcia, David ;
Kaatz, Scott ;
Minichiello, Tracy .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (01) :72-81
[8]   Treatment of the antiphospholipid syndrome with direct oral anticoagulants Position statement of German societies [J].
Bauersachs, Rupert ;
Langer, Florian ;
Kalka, Christoph ;
Konstantinides, Stavros ;
Klamroth, Robert ;
Oldenburg, Johannes ;
Schellong, Sebastian ;
Scholz, Ute ;
Stuecker, Markus ;
Lindhoff-Last, Edelgard .
VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2019, 48 (06) :483-486
[9]   Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research [J].
Bikdeli, Behnood ;
Madhavan, Mahesh V. ;
Gupta, Aakriti ;
Jimenez, David ;
Burton, John R. ;
Nigoghossian, Caroline Der ;
Chuich, Taylor ;
Nouri, Shayan Nabavi ;
Dreyfus, Isaac ;
Driggin, Elissa ;
Sethi, Sanjum ;
Sehgal, Kartik ;
Chatterjee, Saurav ;
Ageno, Walter ;
Madjid, Mohammad ;
Guo, Yutao ;
Tang, Liang V. ;
Hu, Yu ;
Bertoletti, Laurent ;
Giri, Jay ;
Cushman, Mary ;
Quere, Isabelle ;
Dimakakos, Evangelos P. ;
Gibson, C. Michael ;
Lippi, Giuseppe ;
Favaloro, Emmanuel J. ;
Fareed, Jawed ;
Tafur, Alfonso J. ;
Francese, Dominic P. ;
Batra, Jaya ;
Falanga, Anna ;
Clerkin, Kevin J. ;
Uriel, Nir ;
Kirtane, Ajay ;
McLintock, Claire ;
Hunt, Beverley J. ;
Spyropoulos, Alex C. ;
Barnes, Geoffrey D. ;
Eikelboom, John W. ;
Weinberg, Ido ;
Schulman, Sam ;
Carrier, Marc ;
Piazza, Gregory ;
Beckman, Joshua A. ;
Leon, Martin B. ;
Stone, Gregg W. ;
Rosenkranz, Stephan ;
Goldhaber, Samuel Z. ;
Parikh, Sahil A. ;
Monreal, Manuel .
THROMBOSIS AND HAEMOSTASIS, 2020, 120 (07) :1004-1024
[10]   COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow [J].
Bikdeli, Behnood ;
Madhavan, Mahesh V. ;
Jimenez, David ;
Chuich, Taylor ;
Dreyfus, Isaac ;
Driggin, Elissa ;
Der Nigoghossian, Caroline ;
Ageno, Walter ;
Madjid, Mohammad ;
Guo, Yutao ;
Tang, Liang V. ;
Hu, Yu ;
Giri, Jay ;
Cushman, Mary ;
Quere, Isabelle ;
Dimakakos, Evangelos P. ;
Gibson, C. Michael ;
Lippi, Giuseppe ;
Favaloro, Emmanuel J. ;
Fareed, Jawed ;
Caprini, Joseph A. ;
Tafur, Alfonso J. ;
Burton, John R. ;
Francese, Dominic P. ;
Wang, Elizabeth Y. ;
Falanga, Anna ;
McLintock, Claire ;
Hunt, Beverley J. ;
Spyropoulos, Alex C. ;
Barnes, Geoffrey D. ;
Eikelboom, John W. ;
Weinberg, Ido ;
Schulman, Sam ;
Carrier, Marc ;
Piazza, Gregory ;
Beckman, Joshua A. ;
Steg, Gabriel ;
Stone, Gregg W. ;
Rosenkranz, Stephan ;
Goldhaber, Samuel Z. ;
Parikh, Sahil A. ;
Monreal, Manuel ;
Krumholz, Harlan M. ;
Konstantinides, Stavros V. ;
Weitz, Jeffrey I. ;
Lip, Gregory Y. H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (23) :2950-2973